Paper3672575
Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.
Crist KD and 2 others. Ther Drug Monit, 1987. Cited by 49 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Papers, record 3672575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3672575
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Monitoring, Physiologic | Major topic |
| Adult | |
| Aged | |
| Aminoglycosides | |
| Costs and Cost Analysis | |
| Humans | |
| Kidney | |
| Length of Stay | |
| Middle Aged | |
| United States |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39928653 | Characterizing pre-discharge interventions to reduce length of stay for older adults: A scoping review. | PLoS One | 2025 | https://conductscience.org/library/papers/39928653 | PubMed |
| 39011355 | Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit. | J Pharm Policy Pract | 2024 | https://conductscience.org/library/papers/39011355 | PubMed |
| 28178770 | Interventions to improve antibiotic prescribing practices for hospital inpatients. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28178770 | PubMed |
| 27412506 | High throughput LSPR and SERS analysis of aminoglycoside antibiotics. | Analyst | 2016 | https://conductscience.org/library/papers/27412506 | PubMed |
| 27330257 | Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients. | J Basic Clin Pharm | 2016 | https://conductscience.org/library/papers/27330257 | PubMed |
| 25610196 | Therapeutic drug monitoring of gentamicin in patients with bronchopneumonia: cost considerations and patient outcomes. | Eurasian J Med | 2012 | https://conductscience.org/library/papers/25610196 | PubMed |
| 25083229 | Outcomes in patients with gram-negative sepsis treated with gentamicin. | Ther Adv Drug Saf | 2012 | https://conductscience.org/library/papers/25083229 | PubMed |
| 17293388 | Vancomycin administration: the impact of multidisciplinary interventions. | J Clin Pathol | 2007 | https://conductscience.org/library/papers/17293388 | PubMed |
| 11735602 | Pharmacogenetics: the therapeutic drug monitoring of the future? | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11735602 | PubMed |
| 11475466 | Therapeutic drug monitoring: do the improved outcomes justify the costs? | Clin Pharmacokinet | 2001 | https://conductscience.org/library/papers/11475466 | PubMed |
| 10147022 | Pharmacoeconomics of antibacterial treatment. | Pharmacoeconomics | 1992 | https://conductscience.org/library/papers/10147022 | PubMed |
| 10146946 | Methods of minimising the cost of aminoglycoside therapy to hospitals. | Pharmacoeconomics | 1993 | https://conductscience.org/library/papers/10146946 | PubMed |
| 10146877 | Economic aspects of pharmacokinetic services. | Pharmacoeconomics | 1993 | https://conductscience.org/library/papers/10146877 | PubMed |
| 10073735 | The therapeutic monitoring of antimicrobial agents. | Br J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10073735 | PubMed |
| 9655989 | A gentamicin order form improves its use. | West J Med | 1998 | https://conductscience.org/library/papers/9655989 | PubMed |
| 9571300 | Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes? | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9571300 | PubMed |
| 9297729 | Pharmacoeconomics and therapeutic drug monitoring. | Pharm World Sci | 1997 | https://conductscience.org/library/papers/9297729 | PubMed |
| 8527010 | How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions? | Drug Saf | 1995 | https://conductscience.org/library/papers/8527010 | PubMed |
| 8137600 | Cost considerations in therapeutic drug monitoring of aminoglycosides. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/8137600 | PubMed |
| 7988099 | Therapeutic drug monitoring and patient outcome. A review of the issues. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7988099 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3672575
GET https://conductscience.org/api/papers/v1/3672575/cited_by?page=2